A detailed history of Montis Financial, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Montis Financial, LLC holds 13,959 shares of NVO stock, worth $1.52 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
13,959
Previous 16,409 14.93%
Holding current value
$1.52 Million
Previous $2.34 Million 29.04%
% of portfolio
0.59%
Previous 1.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$119.07 - $145.42 $291,721 - $356,278
-2,450 Reduced 14.93%
13,959 $1.66 Million
Q2 2024

Aug 07, 2024

SELL
$122.71 - $146.91 $486,054 - $581,910
-3,961 Reduced 19.45%
16,409 $2.34 Million
Q1 2024

Apr 16, 2024

SELL
$102.11 - $135.92 $37,576 - $50,018
-368 Reduced 1.77%
20,370 $2.62 Million
Q4 2023

Feb 06, 2024

BUY
$87.78 - $105.45 $597,255 - $717,481
6,804 Added 48.83%
20,738 $2.15 Million
Q3 2023

Oct 31, 2023

BUY
$90.94 - $199.54 $1.27 Million - $2.78 Million
13,934 New
13,934 $1.27 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $246B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Montis Financial, LLC Portfolio

Follow Montis Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montis Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Montis Financial, LLC with notifications on news.